EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Somatic dysfunction characterization following acute cerebrovascular disease: the SOMADC-AC study

Alan H Yee iD, William J Brooks iD, Guillermo A Palchik iD, Yueju Judy Li, Beatrice S Akers iD, Michelle L Dossett iD

Journal of Osteopathic Medicine · 23.11.2026

DOI: 10.1515/jom-2025-0239 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Osteopathic Medicine, online erschienen am 23.11.2026. Verfasst von Alan H Yee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of California Davis School of Medicine, Ambulatory Care Center, Sacramento, CA, USA. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

No previous study has systematically quantified somatic dysfunction (SD) in patients with acute cerebrovascular disease nor determined its relationship with focal neurological impairment or quality-of-life (QoL) after stroke. A new diagnostic paradigm, the functional pathology of the musculoskeletal system (FPMSS), may improve examiner reliability to measure musculoskeletal dysfunction and be applicable in patients with cerebral ischemia. The FPMSS methodology provides a semi-quantifiable grading scale, similar to grading reflex or motor power, to measure the disproportion of available motion.

Objectives

The objective of this study was to reliably quantify SD severity in healthy participants and patients with transient ischemic attack (TIA) or acute ischemic stroke. Additionally, we examined the relationships between musculoskeletal dysfunction identified during hospitalization, focal motor deficit severity among those with stroke, and 3-month QoL outcomes after cerebral infarction.

Methods

Healthy asymptomatic participants, patients with TIA (disease control), and those admitted for acute ischemic stroke were recruited from an academic tertiary referral center to undergo standardized musculoskeletal examinations. Participants underwent paired, blinded ratings by two independent raters on the same day. The paired ratings were performed twice in healthy participants (2 weeks apart), once in those with transient cerebral ischemia, and up to three paired instances, 48–72 h apart, for patients admitted with acute stroke. Eighty unique musculoskeletal examination tests were performed on each participant and focused on specified body regions: cervical and thoracolumbar spines, cephalic (“upper”) extremities, innominates, pedal (“lower”) extremities, legs, and feet. All assessments were performed by passive, specified linkage testing for available motion, and all examiners received standardized consensus training in the FPMSS model. Participants with ischemic stroke also underwent neuromotor strength testing, based on the National Institutes of Health Stroke Scale motor subcomponents (NIHSS-motor), at the time of each musculoskeletal assessment, and patient-reported QoL outcomes were obtained three months after discharge in those with cerebral infarction.

Results

A total of 120 participants were enrolled (20 healthy controls, 20 with TIA, 80 with ischemic stroke). Fifty-eight of 120 (48.3 %) participants were female. Changes in speech or language were the most frequent presenting symptom in those with TIA (50 %), whereas weakness affected 71.3 % of the patients presenting with stroke. Nearly two-thirds of the patients with stroke had notable paralysis (e.g., NIHSS-motor≥2), and one-third of the survivors had moderate-severe disability at discharge (modified Rankin Scale [mRS]>2). Compared to healthy participants, patients with cerebral ischemia had significantly greater SD severity. Three-month health-related QoL domains correlated with motor impairment severity from stroke but not with SD burden.

Conclusions

A greater severity of SD is seen in those with acute cerebral ischemia compared to younger healthy asymptomatic participants; however, these findings should be interpreted with caution due to potential measured and unmeasured confounding. Three-month QoL is associated with acute stroke-related motor impairment but did not correlate with SD identified during hospitalization.

Schlagwörter

Stichwörter der Autor:innen

musculoskeletal physiological phenomenaosteopathic medicinequality of lifestroketransient ischemic attack

Autor:innen und Institutionen

  • Department of Neurology, University of California Davis School of Medicine, Ambulatory Care Center, Sacramento, CA, USA.
  • Restorative Care Clinic, Tucson, AZ, USA.
  • Volunteer Clinical Faculty, Department of Neurology, University of California Davis School of Medicine, Sacramento, CA, USA.
  • Division of Transplantation, Department of Surgery, California Pacific Medical Center, San Francisco, CA, USA.
  • Biostatistics Division, Clinical and Translational Science Center (CTSC), University of California Davis School of Medicine, Sacramento, CA, USA.
  • Osteopathic Physician in Private Practice, Davis, CA, USA.

ORCID-Profile: Alan H Yee, William J Brooks, Guillermo A Palchik, Beatrice S Akers, Michelle L Dossett

Zitieren

APA

Yee, A. H., Brooks, W. J., Palchik, G. A., Li, Y. J., Akers, B. S., & Dossett, M. L. (2026). Somatic dysfunction characterization following acute cerebrovascular disease: the SOMADC-AC study. Journal of Osteopathic Medicine. https://doi.org/10.1515/jom-2025-0239

Vancouver

Yee AH, Brooks WJ, Palchik GA, Li YJ, Akers BS, Dossett ML. Somatic dysfunction characterization following acute cerebrovascular disease: the SOMADC-AC study. Journal of Osteopathic Medicine. 2026. doi:10.1515/jom-2025-0239

BibTeX
@article{Yee2026,
  author = {Yee, Alan H and Brooks, William J and Palchik, Guillermo A and Li, Yueju Judy and Akers, Beatrice S and Dossett, Michelle L},
  title = {Somatic dysfunction characterization following acute cerebrovascular disease: the SOMADC-AC study},
  journal = {Journal of Osteopathic Medicine},
  year = {2026},
  doi = {10.1515/jom-2025-0239}
}
Kostenlos starten →